News
TORONTO - Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this respiratory virus season.
Health Canada has authorized updated COVID-19 vaccines by Pfizer and BioNTech and by Moderna for use this respiratory virus ...
Health Canada announced it has approved a new vaccine made by Pfizer Canada and BioNTech for the fall of 2025. According to Canada’s health agency, the vaccine is an updated version of a COMIRNATY ...
One of the highest yields you can get right now is from Pfizer ( PFE 0.90%). The healthcare giant offers a yield of 6.8%, ...
Pfizer's Canadian unit and BioNTech said they have received approval in Canada for their updated Comirnaty Covid-19 vaccine. The companies said Monday the updated vaccine targets the Omicron LP.8.1 ...
An updated guideline on pharmacotherapy of obesity management in adults includes six new and seven revised recommendations, ...
The chapter on Pfizer and BioNTech’s mRNA patent feud with Germany’s CureVac is coming to a close, even as lawsuits over the vaccine technology continue to play out on several other fronts.
Both Pfizer Canada and Moderna Canada told The Canadian Press on Thursday that the U.S. backing away from mRNA vaccines should not affect availability of their updated COVID-19 vaccines in Canada ...
Pfizer CentreOne is one of the industry’s longest-running integrated CDMOs, and it enjoys the ability to tap into Pfizer’s vast manufacturing network, which spans 35 sites around the globe.
Amid thousands of evacuations and the spread of smoke to the United States, the Canadian armed forces and the Coast Guard were summoned to help battle the blazes.
Pfizer’s PFE second-quarter 10% revenue growth and adjusted EPS of $0.78 were ahead of consensus expectations. Management maintained full-year revenue guidance of $61 billion-$64 billion and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results